Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment

We did not find evidence of a substantial negative impact of immediate modification to linezolid among people who developed mild or moderate peripheral neuropathy in the first six months of an individualized regimen. Our results support the clinical practice of cautiously adjusting linezolid when needed to manage non-severe peripheral neuropathy.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-03-16
DOI
https://doi.org/10.64898/2026.03.14.26348377
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment

Aga Krisnanda, Letizia Trevisi, Matthew L. Romo, Palwasha Khan et al.
medRxiv
Tuberculosis Research and Epidemiology
article

Comparative effectiveness of three linezolid management strategies for peripheral neuropathy during multidrug- or rifampicin-resistant tuberculosis treatment

Aga Krisnanda, Letizia Trevisi, Matthew L. Romo, Palwasha Khan, Tinatin Kotrikadze, Hakob Atshemyan, Norbert Ndjeka, Lawrence Oyewusi, Carole D. Mitnick, Catherine Hewison, Michael Rich, Nazgul Samieva, Malik Adenov, Mahmud Rashitov, Abdul Wali Khan, Kwonjune J. Seung, Camilo Gómez-Restrepo, Edwin Herrera Flores, Uzma Khan, Faisal Siraj, Molly F Franke, Andargachew Kumsa, Allison LaHood, Mathieu Bastard, Helena Huerga, Alena Skrahina
article en

Abstract

We did not find evidence of a substantial negative impact of immediate modification to linezolid among people who developed mild or moderate peripheral neuropathy in the first six months of an individualized regimen. Our results support the clinical practice of cautiously adjusting linezolid when needed to manage non-severe peripheral neuropathy.

medRxiv
Almaty Management University (KZ), University of London (GB), Partners In Health (US), Médecins Sans Frontières (UG), Harvard University (US), McGill University Health Centre (CA), London School of Hygiene & Tropical Medicine (GB), Hospital Nacional Cayetano Heredia (PE), Ministry of National Health Services Regulation and Coordination (PK), Ministry of Justice of the Republic of Kazakhstan (KZ), Department of Health (ZA), Ministry of Health (LS), Interactive Research and Development (PK), Harvard Global Health Institute (US), Médecins Sans Frontières (FR), Belarusian National Technical University (BY), Armenian State Pedagogical University after Khachatur Abovian (AM)
Good health and well-being
Openalex Percentile: Top 20%
Tuberculosis Research and Epidemiology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.